Dr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.

Ozempic Weight Loss

Ozempic Weight Loss. Ozempic and many similar diabetes drugs are being used to get rid of the extra pounds. In this article, I will address what Ozempic is, and how Ozempic and other similar drugs work for weight loss, focusing on the Ozempic Pros and Cons and updating the Ozempic lawsuit status.

Ozempic Weight Loss

Ozempic Weight Loss linked to severe gastrointestinal side effects including gastroparesis and ileus.

Legal Help for Victims of Ozempic, Wegovy, or Rybelsus

Ozempic, a blockbuster medication for managing type 2 diabetes, has attracted unwanted attention for its alleged adverse gastrointestinal side effects that have led to legal actions against its manufacturers. The Dr. Shezad Malik Law Firm is helping clients nationwide file Ozempic lawsuits to achieve the justice they deserve. Schedule a free consultation with a qualified attorney today, call 214-390-3190.

Ozempic for weight loss?

Ozempic (semaglutide) works for weight loss by affecting several mechanisms in the body that control appetite and food intake:

  1. GLP-1 Receptor Agonist: Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. GLP-1 is a hormone that is naturally produced in the intestines in response to food intake. By mimicking the action of GLP-1, semaglutide increases insulin release, decreases glucagon secretion, and slows gastric emptying, which can lead to reduced blood sugar levels.
  2. Appetite Suppression: Ozempic affects the areas of the brain that regulate appetite and food intake, leading to a decrease in hunger and increased feelings of fullness. This can result in a lower caloric intake and weight loss over time.
  3. Slowed Gastric Emptying: By slowing down the rate at which the stomach empties, semaglutide can lead to a prolonged feeling of fullness after eating, which helps reduce overall food intake.
  4. Improved Beta-Cell Function: It may also help improve the function of beta cells in the pancreas, which are responsible for insulin production. Better insulin regulation can help manage appetite and prevent overeating.

Why was Ozempic used off label for weight loss treatment?

Ozempic was used off-label for weight loss treatment primarily because of its ability to regulate appetite and satiety, leading to reduced calorie intake and significant weight loss. Here’s why this off-label use became common:
  1. Appetite Suppression: Ozempic mimics the action of the GLP-1 hormone, which is involved in appetite regulation. By activating GLP-1 receptors in the brain, it can decrease hunger and increase feelings of fullness, leading to reduced food intake.
  2. Weight Loss in Diabetic Patients: Initially approved for managing type 2 diabetes, Ozempic was observed to cause weight loss in patients as a side effect. This weight loss is due to the combined effects of improved glycemic control, reduced appetite, and slower gastric emptying.
  3. Clinical Trial Evidence: Studies and clinical trials demonstrated that semaglutide effectively promotes weight loss, not only in individuals with type 2 diabetes but also in those who are overweight or obese without diabetes. This evidence supported its use for weight management.
  4. Increasing Demand for Weight Loss Solutions: With the rising prevalence of obesity worldwide, there has been a growing demand for effective weight loss treatments. Medications like Ozempic that can offer significant weight loss benefits have attracted attention for off-label use in managing obesity.

Due to the successful results in weight loss seen in clinical trials and real-world use, the demand for Ozempic as a weight loss treatment increased, leading to its off-label use.

How does Ozempic affect the Brain?

Ozempic affects the brain primarily through its role as a GLP-1 receptor agonist, which influences several processes related to appetite and satiety. Here’s how Ozempic can impact the brain:

  1. Appetite Regulation: Ozempic acts on GLP-1 receptors in the brain, particularly in areas involved in regulating hunger and satiety, such as the hypothalamus. By activating these receptors, it helps reduce appetite and increase feelings of fullness, leading to a reduction in food intake and potentially contributing to weight loss.
  2. Reward Processing: There is evidence suggesting that GLP-1 receptor agonists like Ozempic can affect the brain’s reward system, which is involved in the pleasure and reward aspects of eating. By influencing this system, Ozempic may reduce the reward-driven eating behavior, helping individuals to decrease their calorie intake.
  3. Blood Sugar Regulation: Although the primary effects on blood sugar regulation occur in the pancreas and liver, the brain also plays a role in glucose homeostasis. By improving insulin sensitivity and reducing blood sugar levels, Ozempic can indirectly affect how the brain responds to and processes glucose, which is its main energy source.

The effects of Ozempic on the brain contribute to its efficacy in reducing appetite and aiding weight loss, in addition to its primary use in improving glycemic control in type 2 diabetes. However, the exact mechanisms of how GLP-1 receptor agonists influence brain function and behavior are still under research.

Ozempic Pros and Cons

Ozempic is a medication used primarily for managing type 2 diabetes, and it has also been found effective in weight management. Here are some pros and cons associated with its use:

Ozempic Pros

  • Effective Blood Sugar Control: Ozempic has been shown to effectively lower blood sugar levels in adults with type 2 diabetes, which can help in managing the condition and reducing the risk of complications.
  • Weight Loss: It has been associated with significant weight loss in some people, due to its ability to reduce appetite and food intake.
  • Cardiovascular Benefits: Studies have suggested that semaglutide can reduce the risk of major cardiovascular events, such as heart attack and stroke, in people with type 2 diabetes and heart disease.
  • Once-Weekly Dosing: It is administered via injection once a week, which may be more convenient than medications requiring daily dosing.

Ozempic Cons

  • Gastrointestinal Side Effects: Common side effects include nausea, vomiting, diarrhea, stomach pain, and constipation. Serious side effects include stomach paralysis, also known as gastroparesis and ileus which is a blockage of the small intestines. These are typically most pronounced when starting treatment.Ozempic can affect gastric motility, which is the speed at which the stomach empties its contents into the small intestine. This effect can lead to gastroparesis in some patients, where gastric emptying is delayed.Here’s how the link between Ozempic and gastroparesis unfolds:

    Gastroparesis is a chronic condition characterized by delayed gastric emptying in the absence of any mechanical obstruction, and it can have various underlying causes, including diabetes itself.

    1. Slowed Gastric Emptying: One of the primary actions of GLP-1 receptor agonists like Ozempic is to slow down gastric emptying. This is beneficial for blood sugar control as it leads to a slower release of glucose into the bloodstream after eating, helping to prevent spikes in blood sugar levels.
    2. Symptoms of Gastroparesis: Slowing gastric emptying can mimic symptoms of gastroparesis, such as nausea, vomiting, abdominal pain, bloating, and a feeling of fullness after eating only a small amount of food. These symptoms are common side effects of Ozempic, especially when treatment is initiated or the dose is increased.
  • Risk of Hypoglycemia: When combined with other diabetes medications, especially those that increase insulin production, there’s an increased risk of low blood sugar (hypoglycemia).
  • Expensive: Ozempic can be quite costly, which may be a concern for patients without insurance coverage or with high deductibles.
  • Injection-Based: As an injectable medication, it may not be preferred by individuals who are uncomfortable with needles.

As a result of the drug manufacturer’s failure to disclose the serious gastroparesis risks on the warning label, a increasing number of Ozempic, Wegovy, and Mounjaro lawsuits are now being filed, each alleging that critical information was withheld from patients and the doctors to increase profits.

Here’s how the link between Ozempic and ileus unfolds:

Ozempic and ileus (a temporary and often painful lack of movement in the intestines) can occur. Because Ozempic can affect gastrointestinal motility, there is a concern that it might contribute to conditions like ileus in certain circumstances. Here’s how they might be related:

  1. Gastrointestinal Motility Effects: Ozempic slows gastric emptying as part of its therapeutic action to control blood sugar levels. While primarily affecting the stomach, it can also influence motility along the entire gastrointestinal tract.
  2. Potential for Intestinal Disturbance: By altering normal digestive processes, there is a risk that GLP-1 receptor agonists like Ozempic could affect intestinal motility.
  3. Risk Factors and Pre-existing Conditions: Patients with existing gastrointestinal disorders or those at higher risk for motility issues might be more susceptible to complications when using medications that affect gastrointestinal function.

What is Wegovy?

Wegovy is a higher-dose version of Ozempic. Wegovy has the same active ingredient as Ozempic, Wegovy is specifically approved as a diet drug and is now used by millions of Americans across the USA and world wide.

Both Ozempic and Wegovy are glucagon-like peptide-1 receptor agonists (GLP-1 RA), which also include Mounjaro and Zepbound.

March 2024 Ozempic, Wegovy and Mounjaro Stomach Paralysis Lawsuit Update

All GLP-1 federal lawsuits are centralized and consolidated, transferring claims brought nationwide to U.S. District Judge Gene Pratter in the U.S. District Court for the Eastern District of Pennsylvania, for coordinated discovery and pretrial proceedings.

At least 55 lawsuits claim that drugmakers Novo Nordisk and Eli Lilly failed to warn patients about serious side effects associated with their blockbuster diabetes and weight loss drugs Ozempic and Mounjaro.
According to court records, 55 lawsuits have been filed against these companies by patients who say they were prescribed the drugs to treat their diabetes or to help with weight loss but weren’t warned about severe side effects including gastroparesis, or stomach paralysis, and intestinal obstruction.

Dr. Shezad Malik Law Firm Investigating Ozempic, Wegovy and Mounjaro Cases Nationwide

Did you or a loved one experience gastroparesis, and ileus injuries after taking Ozempic, Wegovy, Rybelsus, or Mounjaro? Dr. Shezad Malik law firm based in Dallas, Texas is now reviewing gastrointestinal injuries after taking Ozempic, Wegovy, Rybelsus, Mounjaro or other GLP-1 agonists cases nationwide. Please call 214-390-3189 or email us for further information.

Read More Here

Lawsuit claims Ozempic and Mounjaro Cause Severe Gastroparesis

Ozempic Gastro Effects

Ozempic, Hero or Villain?



Contact Information